Information Library
Enrollment & retention - High-quality studies
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Nasal Influenza Vaccine
September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. -
Diabetes Outcomes
September 8, 2009
This Phase IIIB diabetes study involved cardiovascular outcomes assessed over 6 years. Learn how Quintiles helped the customer overcome the challenges of patient retention, data collection and evaluation. -
Phase One Services: Professor Anders E. Grahnen
July 24, 2009
With the current high costs of drug development, it's crucial that you can establish the potential success of your agent before the end of Phase II. Our market-leading expertise in biomarkers and specialist techniques can help you do just that. -
QUINTILES ANNOUNCES NEW GHANA OFFICE
June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana. -
Antibiotic Safety Assessment
March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (5 items)